Post by Beofor Research Consulting

Scaling Science Into Impact At Beofor Research Consulting, we help biotech and emerging pharma companies turn ambitious science into operational reality. From building lean, inspection-ready operating models to optimizing CRO and vendor governance, we embed as Fractional or full-time COOs to accelerate IND-to-Phase IV programs, protect runway, and de-risk portfolios. With 25+ years leading 150+ global studies at J&J and Eli Lilly — including oversight of $100M+ annual budgets — we know what it takes to scale operations without bureaucracy. Whether you’re preparing for an IND, scaling into Phase II and beyond, or establishing your first enterprise-grade clinical infrastructure, we partner with leadership teams to get programs moving fast, on budget, and inspection-ready. 💡 Let’s connect if you want to explore how we can scale your operations for your next milestone. Beofor.ca